Previous Investigations
Other Litigations Attorney for Strattera Lawsuit Research Center
|
Learn More about Strattera
Atomoxetine hydrochloride is a prescription drug used in the treatment of attention-deficit hyperactivity disorder (ADHD).
It is manufactured and marketed under the brand name Strattera® by Eli Lilly and Company.
Atomoxetine is classified as a selective norepinephrine reuptake inhibitor, and is approved for use in children, adolescents, and adults.
However, its efficacy has not been studied in children under 6 years old.
Its advantage over stimulants for the treatment of ADHD is that it is not considered to have significant abuse potential, is not scheduled as a controlled substance and has proven in clinical trials to offer 24 hour coverage of symptoms associated with ADHD in adults and children.
Weitz & Luxenberg is no longer accepting Strattera cases.
see also:
Jaundice
Strattera & Jaundice - Strattera increases Jaundice riskStrattera increases Jaundice risk in its users - Are you at risk?
Liver Damage
Learn about the symptoms of liver damage from StratteraStrattera can cause liver damage in its users.
News & Warnings
Get the latest news about the dangers of Strattera from a lawyerBreaking news from a Strattera lawyer about this dangerous drug
